Abstract. We have cloned from a mouse placenta cDNA library a mouse homologue of the human stromelysin-3 (ST3) eDNA, which codes for a putative matrix metalloproteinase expressed in breast carcinomas. The ST3 protein is well conserved between humans and mice, and the pattern of ST3 gene expression is similar in both species, and shows expression in the placenta, in the uterus, and during limb bud morphogenesis. We show that the ST3 gene can also be expressed in the normal mouse mammary gland. ST3 gene expression was not detected during mammary growth, neither in virgin nor in pregnant mice, but was specifically observed during postlactating involution of the gland, an apoptotic process associated with intense extracellular matrix remodeling. ST3 transcripts were found in fibroblasts immediately surrounding degenerative ducts, suggesting that ST3 gene expression may be associated with the basement membrane dissolution, which occurs during mammary gland involution. Since the ST3 gene is also specifically expressed in fibroblastic cells surrounding invasive neoplastic cells of breast carcinomas, we suggest that ST3 is implicated in extraceIlular matrix remodeling processes common to mammary apoptosis and breast cancer progression.
Abstract. We have cloned from a mouse placenta cDNA library a mouse homologue of the human stromelysin-3 (ST3) eDNA, which codes for a putative matrix metalloproteinase expressed in breast carcinomas. The ST3 protein is well conserved between humans and mice, and the pattern of ST3 gene expression is similar in both species, and shows expression in the placenta, in the uterus, and during limb bud morphogenesis. We show that the ST3 gene can also be expressed in the normal mouse mammary gland. ST3 gene expression was not detected during mammary growth, neither in virgin nor in pregnant mice, but was specifically observed during postlactating involution of the gland, an apoptotic process associated with intense extracellular matrix remodeling. ST3 transcripts were found in fibroblasts immediately surrounding degenerative ducts, suggesting that ST3 gene expression may be associated with the basement membrane dissolution, which occurs during mammary gland involution. Since the ST3 gene is also specifically expressed in fibroblastic cells surrounding invasive neoplastic cells of breast carcinomas, we suggest that ST3 is implicated in extraceIlular matrix remodeling processes common to mammary apoptosis and breast cancer progression.
S
TROMELYSIN-3 (ST3) ~ (Basset et al., 1990 ) is a putative new member of the family of matrix metalloproteinase (MMP) enzymes whose substrates are extracellular matrix (ECM) components (Matrisian, 1990) . ST3 substrate specificity is not known, but the ST3 sequence differs from those of the previously characterized MMPs in ways that suggest that it may be the first member of a new MMP subgroup (Basset et al., 1990; Murphy et al., 1991; Levy et al., 1992) . It has been proposed, and to some extent demonstrated, that MMPs are involved in several physiological and pathological processes in which tissue remodeling is implicated, such as embryonic development, wound healing, and tumor invasion (Matrisian, 1990; Liotta and StetlerStevenson, 1990 ). In agreement with this concept, the ST3 gene is specifically expressed in fibroblastic cells immediately surrounding invasive neoplastic cells in several types of human carcinomas (Basset et al., 1990; and our unpublished results) . The gene is also expressed in mesenchymal cells during limb bud morphogenesis, which suggests that ST3 may be a stroma-derived factor implicated in normal development that has been subverted in the cancer process.
In mouse, the mammary gland undergoes most of its morphogenetic and functional changes postpartum, under hormonal and growth factors that control both the epithelial and mesenchymal elements (Vonderhaar, 1988; Coleman et al., 1988; Robinson et al., 1991, and references therein) . In vitro and in vivo studies have shown that growth and differentiation of mouse mammary gland are dependent on ECM remodeling (Vonderhaar, 1988; Silberstein et al., 1990; Talhouk et al., 199I) , and that mammary gland involution is an apoptotic process at least partially directed by basement membrane dissolution (Wicha et al., 1980; Streuli et al., 1991) .
To investigate whether the ST3 gene was expressed during mouse mammary gland development, we have cloned the mouse equivalent of human ST3 eDNA, and used the eDNA as a probe to detect ST3 gene expression. Our results show that the ST3 gene is not expressed in the mammary gland during gestation and lactation, but is specifically expressed during mammary involution, after weaning. ST3 RNA was detected in fibroblasts immediately surrounding degenerating mammary ducts, which suggests that ST3 gene expression in the mammary gland is associated with a basement membrane remodeling process common to apoptosis and cancer invasion.
Materials and Methods 77ssue Collection
Mammary glands at different stages of development were surgically excised from female mice and immediately frozen in liquid nitrogen until RNA ex- 
RNA Isolation and Northern Blot Analysis
Total RNA used to construct the mouse placenta cDNA library was prepared by the guanidinium-cesium chloride procedure, and poly(A) + RNA was purified by oligo(dT)-cellulose chromatography. All other RNA samples were prepared by the method of Chomczynski and Sacchi (1987) . RNAs were fractionated by electrophoresis in 1% agarose gels in the presence of formaldehyde and transferred to nylon membranes (hybond N;
Figure 2. , 1990) . Starting from the 5' end, the underlined sequences correspond to the "cysteine switch" sequence characteristic of MMPs prodomain (Matrisian, 1990) , and to the putative zinc-binding region (Vallee and Auld, 1990 ).
(AMV)-reverse transcriptase by using placenta poly(A) + RNA primed with oligo(dT) and random hexamers. The second strand was synthesized by using RNase H and DNA polymerase I (Gubler and Hoffman, 1983) . Double-stranded eDNA was cloned into the EcoRI site of the h gtl0 vector after ligation to adaptators, according to the procedure of Sartoris et ai. (1987) , The ligation reaction was packaged in vitro and the resulting library was plated out on LB agar plates. 4 • 104 recombinant phages were screened using replica nylon filters (Biodyne A; Pall Corporation, East Hills, NY) hybridized with riP-labeled human ST3 eDNA (Basset et al., 1990) , at 370C in the presence of 50% formamide. Washings were performed in 2x SSC, 0.1% SDS at 220C, followed by 0.1x SSC, 0.1% SDS at 55"C. After autoradiography, three positive plaques were detected.
Subcloning and Sequencing
The three purified recombinant phages detected with the human ST3 eDNA probe were amplified, and the phage DNA, prepared according to standard procedure, was digested with EcoRI enzyme. The longest eDNA insert (2.3 kb) was subcloned in M13 sequencing vector and DNA sequence was determined by the dideoxy chain termination method, using Sequenase and a deaza-dGTP reagent kit (U.S. Biochemical Corp., Indianapolis, IN). The sequence was analyzed with the PC/GENE software package.
In Situ Hybridization
Deparaflinized and acid-treated sections (6 ttm thick) were treated with proteinase K and hybridized overnight with 35S-labeled antisense transcripts from a mouse ST3 eDNA insert (nucleotides 1-1744), subcloned in pBluescript H (Stratagene, La JoUa, CA). Hybridization was followed by RNase treatment (20 #g/ml 30 min, 37~ and two stringent washings (2x SSC, 50% formamide, 60~ 2 h), before autoradiography using NTB2 emulsion (Kodak). Autoradiography was for 20 d, and after developing, the slides were counterstained with hematoxylin.
Results

Cloning and Sequencing of mouse ST3 cDNA
We assumed that the ST3 gene, which is expressed at a high level in human placenta (Basset et al., 1990) , would be also expressed in mouse placenta. Indeed, a 2.4-kb transcript was detected by Northern blot analysis of mouse placenta poly(A) § RNA using a 32p-labeled human ST3 cDNA probe (see Materials and Methods). A mouse placenta cDNA library was constructed in the )~ gtl0 vector and 4 • 104 clones were screened with the human ST3 eDNA probe. Three positive clones were obtained, and the longest insert (2.3 kb) was subcloned into a M13 vector and sequenced. The result of the sequence analysis showed that this insert corresponded to a potential full-length mouse ST3 cDNA of 2,260 nucleotides (Fig. 1) . The open reading frame is predicted to encode a 492-residue protein exhibiting 80 % sequence homology with the 488-amino acid residues of human ST3 (Fig. 2) . The putative mouse protein has an hydrophobic NH~-terminal sequence (residues 1-35 or 1-37), which is a candidate leader sequence, and contains a Leu-Arg-Cys-GlyVal-Pro-Asp (LRCGVPD, single-letter amino acid code; residues 82-88) similar to the PRCGVPD sequence characteristic of the prodomain of MMPs (Matrisian, 1990) . The 10 amino acids characteristic of human ST3, at the junction between the ST3 prodomain and the domain of the putative mature enzyme (Basset et al., 1990) , are also present in the mouse protein sequence (residues 92-101) and 80% conserved between mouse and human (Fig. 2) . By analogy with the other MMPs, the mature mouse protein is predicted to start at phenylaianine 102 (Basset et al., 1990) ; it exhibits 89% sequence homology with the corresponding human ST3 form (starting at phenylalanine 98) (Fig. 2 ). An even higher homology (94%) is observed when the comparison is limited to the putative catalytic domain of both proteins (residues 102-254 and 98-250 for mouse and human ST3, respectively), which contains a Zn binding region identical in both species (residues 216-226 of mouse ST3) (Fig. 2) .
That the mouse eDNA we had cloned corresponded to a mouse ST3 cDNA was further supported by studying the expression pattern of the corresponding gene in mouse tissues. Mouse ST3 transcripts were found to be expressed in the limb bud during morphogenesis, in the placenta and uterus, but not in the normal colon, intestine, liver, lung, kidney, heart, spleen, brain, and testis (data not shown), as expected from our previous results in human tissues (Basset et al., 1990) . However, the ST3 gene, which is not expressed in normal human skin (Basset et al., 1990) , was expressed at low levels in mouse skin (data not shown).
ST3 Gene Expression in the Normal Mammary Gland
The branching growth of mammary ducts involves a complex interplay between epithelium and mesenchyme that is controlled by mammotrophic hormones. At ~4 wk of age, after the onset of ovarian secretion, small dense end buds appear at the ductal tips. These structures, consisting of layers of actively dividing epithelial and myoepithelial cells, serve as growth points for the elongation and branching of new ducts (Coleman et al., 1988; Vonderhaar 1988; Snedeker et al., 1991) . At 8-10 wk postpartum, the entire mammary fat pad is filled with a highly branched network of epithelial ducts enveloped in a fibrous sheet of extracellular matrix (Silberstein et al., 1990) . When the sexually mature female becomes pregnant, the mammary glands begin a cycle of lobulo-alveolar development that ultimately results in full functional differentiation and the production of milk (Topper and Freeman, 1980) . No ST3 gene expression could be detected by Northern blot analysis during the growth of mouse mammary gland. The gene was not expressed in virgin mice, nor in pregnant mice or during lactation (Fig. 3, lanes 1-7) . However, ST3 gene expression was detected 3 d after weaning (Fig. 3 , lane 1/), in the involuting mammary gland. The expression was maximal 6 d after weaning (Fig. 3, lane 14) , persisted at lower levels for an additional 2 wk (Fig. 3, lanes 15-18) , and totally disappeared at the onset of the second gestation (Fig.   3, lanes 19 and 20) .
The results of in situ hybridization experiments were consistent with those obtained by Northern blot analysis. No ST3 RNA could be detected in mouse mammary gland sections during the first 2 d after weaning (Fig. 4, a-c) , during which milk is still produced and distends the alveolar structures (Martinez-Hernandez et al., 1976) . However, ST3 gene expression was observed between days 4 and 20 after weaning (Fig. 4, d-l) , when ECM remodeling is prominent and apoptosis of epithelial cells is occurring in the involuting mammary gland (Wicha et al., 1980) . At day 4 (Fig. 4, d-f ) and at day 7 (Fig. 4, g-i) , ST3 RNA was detected in fibroblasts immediately surrounding disorganized clusters of epithelial cells, but not in fibroblasts at a distance from epithelial cords, nor in the epithelial cells themselves. In the following days, ST3 RNA was still observed in fibroblasts surrounding neoformed mammary structures (Fig. 4, j-l) , but the number of ST3-expressing areas decreased markedly between days 7 and 20 after weaning (data not shown).
Discussion
We have isolated and characterized the cDNA corresponding to the mouse equivalent of the human MMP ST3 gene. The sequences of the human and mouse putative proteins are well conserved and exhibit the structural characteristics of other members of the MMP family. The 10 amino acids that are specific to human ST3, and are located precisely at the putative proprotein cleavage site 03asset et al., 1990) , are also present in mouse ST3 and well conserved, suggesting that this short unique sequence may be important in proST3 activation. The expression pattern of the ST3 gene is similar in After electrophoresis and blotting, the filters were stained with methylene blue before hybridization, as described in Materials and Methods. A 2.4-kb ST3 transcript was detected in lanes 11-1& corresponding to involuting mammary glands between days 3 and 20 postweaning. The methylene blue-stained 28S ribosomal RNA was used to reflect the amount of total RNA loaded on each lane. mice and in humans, with high levels of expression in the uterus, in the placenta, and in the limb bud during embryogenesis.
ECM is an important regulator of mammary cell function in the mouse, and ECM remodeling accompanies the anatomical changes in the mammary gland during gestation, lactation, and involution (Wicha et al., 1980; Walker et al., 1989; Silberstein et al., 1990; Streuli et al., 1991, and references therein) . Several proteinases have been implicated in these processes, including the urokinase plasminogen activator and a type IV collagenase (Ossowski et al., 1979; Talhouk et al., 1991) . Urokinase activity is transiently increased after the initiation of mammary involution (Ossowski et al., 1979) , while active type IV collagenase is absent during early involution, but appears 3-4 d after weaning, when massive restructuring of the ECM occurs (Talhouk et al., 1991) . In this respect, there is a parallel between type IV collagenase expression and ST3 gene expression, which is also initiated 3--4 d after weaning. However, the active form of type IV collagenase is also abundant during pregnancy (Talhouk et al., 1991) , while ST3 gene expression is specific to mammary gland involution.
It may be paradoxical that the ST3 gene, which is not expressed during mammary growth, is expressed both in breast carcinoma and during mammary involution, an apoptotic process characterized by epithelial cell death and commonly regarded as being the opposite of cell proliferation (Kerr et al., 1972; Gullino, 1980) . However, it has been proposed that apoptosis and proliferation may use common molecular pathways (Evan et al., 1992) , and, furthermore, another relationship between mammary involution and breast carcinoma is that both processes are characterized by basement membrane lysis. The basement membrane appears to play a central role in the function of normal mammary epithelial ceils, and its dissolution during mammary involution correlates with functional regression of the mammary gland (Martinez-Hernandez et al., 1976; Wicha et al., 1980; Talhouk et al., 1991; Streuli et al., 1991) . Thus, ST3 gene expression may be associated with basement membrane remodeling that occurs both during breast carcinoma progression and during manunary gland involution. Consistent with this hypothesis, in both processes, the ST3 gene is exclusively expressed in fibroblastic cells immediately surrounding epithelial cells.
It remains to be seen whether ST3 participates, possibly with other proteinases such as urokinase and type IV collagenase, in basement membrane remodeling or whether ST3 gene expression is secondary to basement membrane remodeling. In the latter case, ST3 gene expression may result from the transient contact between epithelial and stromal compartments, or from the action of components released during the degradation of the basement membrane itself, including growth factors known to be tightly associated with the basement membrane (Ruoslahti and Yamaguchi, 1991; Flaumenhaft and Rifldn, 1991). In any event, the observation that the ST3 gene is expressed both during breast carcinoma progression and during mammary gland involution further supports the concept that ST3 gene expression plays a role in normal processes and is subverted in breast carcinoma.
